Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study
作者： K.S. Tewari , J.J. Java , R.N. Eskander , B.J. Monk , R.A. Burger
关键词: Ovarian carcinoma 、 Ovarian cancer 、 Debulking 、 Stage (cooking) 、 Bevacizumab 、 Chemotherapy regimen 、 Maintenance therapy 、 Internal medicine 、 Surgery 、 Oncology 、 Medicine 、 Gynecologic oncology
摘要: Background To determine whether time from surgery to initiation of chemotherapy impacts survival in advanced ovarian carcinoma. Patients and methods This is a post-trial ad hoc …
annalsofoncology.org
oup.com
oxfordjournals.org
sci-hub.se 参考文章(36)
Griffiths Ct, Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. National Cancer Institute monograph. ,vol. 42, pp. 101- 104 ,(1975)
David R. Cox, Regression Models and Life-Tables Springer Series in Statistics. ,vol. 34, pp. 527- 541 ,(1992) , 10.1007/978-1-4612-4380-9_37
Elizabeth A. Saffer, Nurten Gunduz, Bernard Fisher, Influence of the Interval between Primary Tumor Removal and Chemotherapy on Kinetics and Growth of Metastases Cancer Research. ,vol. 43, pp. 1488- 1492 ,(1983)
G A Omura, B N Bundy, J S Berek, S Curry, G Delgado, R Mortel, Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology. ,vol. 7, pp. 457- 465 ,(1989) , 10.1200/JCO.1989.7.4.457
A V Khrunin, A Moisseev, V Gorbunova, S Limborska, Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients Pharmacogenomics Journal. ,vol. 10, pp. 54- 61 ,(2010) , 10.1038/TPJ.2009.45
H. B. Mann, D. R. Whitney, On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other Annals of Mathematical Statistics. ,vol. 18, pp. 50- 60 ,(1947) , 10.1214/AOMS/1177730491
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
Ramez N. Eskander, Krishnansu S. Tewari, Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma—Mechanistics, review of phase III randomized clinical trials, and regulatory implications Gynecologic Oncology. ,vol. 132, pp. 496- 505 ,(2014) , 10.1016/J.YGYNO.2013.11.029
Torbjørn Paulsen, Janne Kærn, Kristina Kjærheim, Tor Haldorsen, Claes Tropé, Influence of interval between primary surgery and chemotherapy on short-term survival of patients with advanced ovarian, tubal or peritoneal cancer. Gynecologic Oncology. ,vol. 102, pp. 447- 452 ,(2006) , 10.1016/J.YGYNO.2006.01.035
Dawn Hershman, Michael J. Hall, Xiaoyan Wang, Judith S. Jacobson, Russell McBride, Victor R. Grann, Alfred I. Neugut, Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer Cancer. ,vol. 107, pp. 2581- 2588 ,(2006) , 10.1002/CNCR.22316